News about Drug Discovery & Development

Bespak Partners with H and T Presspart to Boost Transition to Low GWP Propellants in pMDIs

Bespak has teamed up with H&T Presspart to accelerate the industry’s transition from existing pressurised Metered Dose Inhaler (pMDI) formulations to more climate-friendly alternatives utilising low global warming potential (GWP) propellants.

Drug Discovery & Development | 04/05/2024 | By Aishwarya |  495

Dr. Reddys Laboratories Unveils Broad-Spectrum Antibiotics in USA

Dr. Reddy’s Laboratories Ltd. has introduced Doxycycline Capsules, 40 mg in the US market.

Drug Discovery & Development | 04/05/2024 | By Aishwarya |  1063

ProPharma and PBL Develop Cell and Gene Therapy Manufacturing Device

ProPharma has announced its collaboration with PBL and have jointly developed an enclosed, fully automated cell factory device, the Cell Factory Box (CF Box).

Drug Discovery & Development | 04/05/2024 | By Aishwarya |  548

Astellas Signs License Deal with Poseida to Develop Novel Allogeneic Cell Therapies

Astellas Pharma Inc. has announced that Xyphos Biosciences, Inc., a wholly owned subsidiary of Astellas and Poseida have signed a research collaboration and license agreement to develop novel convertibleCAR programs by combining the innovative cell therapy platforms from each of the companies.

Drug Discovery & Development | 03/05/2024 | By Aishwarya |  442

Scenic Biotech Enters into Research Partnership with Bristol Myers Squibb

Scenic Biotech has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb’s drug targets by identifying target biology for indication selection and expansion.

Drug Discovery & Development | 01/05/2024 | By Aishwarya |  466

Lupin Launches Mirabegron Extended-Release Tablets in US

Lupin Ltd. has developed Mirabegron Extended-Release Tablets, 25 mg, in the United States, after having received approval from the United States Food and Drug Administration (US FDA).

Drug Discovery & Development | 22/04/2024 | By Aishwarya |  626

SII Joins Hands with Univercells to Make Personalized Oncology Affordable

The new therapies are developed using genetic material extracted from the patient’s tumors, a process which is both time-consuming, and expensive.

Drug Discovery & Development | 12/04/2024 | By Manvi |  676

Syntekabio to Showcase its AI Drug Discovery Tech at Bio-IT World Expo

Syntekabio, a global artificial intelligence (AI) drug discovery pioneer, has announced its participation at the upcoming Bio-IT World Conference & Expo.

Drug Discovery & Development | 12/04/2024 | By Aishwarya |  622

Harmony Biosciences Signs Agreement with Bioprojet to Develop, Manufacture and Commercialize TPM-1116

TPM-1116 represents a new chemical series of OX2R agonists with the potential for a best-in-class clinical profile.

Drug Discovery & Development | 11/04/2024 | By Manvi |  870

Sartorius and TheWell Bioscience to Enable More Accurate Predictions in Drug Discovery

Sartorius has teamed up with TheWell Bioscience on the further development of hydrogels and bioinks tailored to produce 3D advanced cell models for drug discovery workflows.

Drug Discovery & Development | 10/04/2024 | By Aishwarya |  358